Access cutting-edge alopecia areata treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access alopecia areata specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alopecia areata treatment provided free
The main purpose of this study is to measure the efficacy of farudodstat compared to placebo at Week 12 from the treatment start, in adult participants with Alopecia Areata (AA) with 30% or greater scalp hair loss.
Sponsor: ASLAN Pharmaceuticals
Check if you qualify for this alopecia areata clinical trial in Birmingham, AL
If you're searching for alopecia areata treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alopecia areata specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.